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Background: Lymphotoxin- (LT-), interleukin-6 (IL-6) and
nterleukin-1beta (IL-1) are proinﬂammatory cytokines playing
mportant roles in immunity against Leishmania infection and the
utcome of the disease. As cytokine productions are under the
enetic control, this study tried to ﬁnd any probable relationship
etween these cytokinegenepolymorphismsand the susceptibility
o visceral leishmaniasis (VL) in Iranian pediatric patients.
Methods: 95 pediatric patients involved with visceral leishma-
iasis and 128 non-relative healthy people, from the same area as
he patients, were genotyped for LT- (+252 A/G), IL-6 (-174C/G)
nd IL-1 (+3953 T/C and -511T/C) gene polymorphisms using
olymerase chain reaction-restriction fragment length polymor-
hism (PCR-RFLP).
Results:Therewasnot found any signiﬁcant differences in allele
nd genotype frequencies of LT- (+252 A/G), IL-6 (-174C/G) and
L-1 (+3953) among the study groups. However, the frequency
f IL-1 -511TT genotype was higher in the controls (P =0.0004)
hile the frequency of IL-1 -511CC genotype and C allele were
igher in the patients (P =0.008 and P=0.00006, respectively). Fur-
hermore, IL-1 CC (-511/ +3953) haplotype was more frequent in
L patients compared with the controls (P =0.0002) and the distri-
ution of TT haplotype was higher in controls compared with the
atients (P =0.003).
Conclusion: Based on the results IL-1 -511C allele, CC geno-
ype and CC (-511/ +3953) haplotype could be considered as the
usceptibility factors for visceral leishmaniasis while IL-1 -511TT
enotype, Tallele andTThaplotype (-511/ +3953)mightbecounted
s the inﬂuential factors for resistance to the disease.
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Malaria: incidence, clinical proﬁle, complications, treatment
options: study from a rural medical college hospital in south
India. (Any case of fever is malaria until proven otherwise: still
holds true in India!)
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Chittor., ANDHRA PRADESH, India
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Background: Malaria is the commonest parasitic infection in
India. TheNational Vector BorneDisease Control Programme (NVB-
DCP) reports 2 million parasite positive cases a year. The WHO
estimates 100 million cases in the south East Asian Region, 70% of
these in India. Independent studies by the IndianCouncil ofMedical
Research have unequivocally established that malaria incidence is
hugely under-estimated.
Epidemiology is complex because of geo-ecological diversity,
multi-ethnicity, and wide distribution of anopheline malaria.
The countrywide presence is facilitated by inter-and intra-state
population movement.
A shift in the clinical proﬁle inpatientswith complicatedmalaria
has been observed with multiple organ dysfunction becoming a
common feature.
Anti-malarial drugs available include chloroquine, quinine, and
artemesinin compounds.
Methods: To assess the incidence of malaria, clinical proﬁle and
course of the disease, and response to different treatment options
available.
All cases of conﬁrmed malaria, clinically diagnosed malaria and
treated with anti-malarial drugs from January 2011 to December
2011 were analysed for fever pattern, clinical features, hospitaliza-
tion, complications and mortality rate.
Results:A total of 174 caseswere diagnosed / treated asmalaria.
93 were male and 81 female. Complicated malaria was seen in 38
cases (21.83%) with positivity in 20 cases. Mortality was 04.59% of
clinicalmalaria cases, all admittedwithmultiple organ dysfunction
syndrome, no mortality in conﬁrmed cases. Of the remaining 136
cases malarial was conﬁrmed in 42, while 94 were clinical malaria.
18 were positive for P.falciparum, 18 for P.vivax. 6 patients were
positive for both falciparum and vivax. All patients were treated
with anti-malarial with recovery. Chlroquine was used in those
diagnosed as clinical malaria, followed by quinine and Artemisinin
in both clinical and conﬁrmed cases depending upon the clinical
severity.
Conclusion: Malaria was positive in only 35.63%, remaining
being clinically / therapeutically proven malaria cases. Clinical
malaria patients had palpable spleen as clinical sign, along with
fever, chills and rigors.
Clinical suspicion and early initiation of treatment helps in
recovery.
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Results of the present study provides evidence that any case of
ever is malaria until proven otherwise still holds true for tropical
ountries like India.
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ffectiveness and compliance of long lasting insecticide –
reated nets (LLINs) on malaria parasitemia in some pregnant
omen attending antenatal clinic in Rivers State Nigeria.
. Nduka1,∗, M. Wogu2
ABIA STATE UNIVERSITY, Uturu, Nigeria
University of Port Harcourt, Port Harcourt, Nigeria
Background: A study to evaluate the effectiveness and compli-
nce of long lasting insecticide – treated nets (LLINs) on malaria
arasitemia in some pregnant women attending antenatal clinic
n ﬁve healthcare centres in Rivers State was carried out to offer
nsight into Government efforts at Bednet distribution.
Methods:A total of 400 pregnantwomen in different trimesters
ere examined for malaria parasites. Blood samples were col-
ected by vein puncture and the presence of malaria parasites was
bserved microscopically on thick and thin blood smears prepared
rom each sample. Personal data were also collected through ques-
ionnaires. The results gotten were analyzed statistically using the
hi – square test of signiﬁcance.
Results: A total of 104 (26%) pregnant women out of the 400
xamined were infected. Out of the 400 pregnant women exam-
ned, 317 (79%) used LLINs while 83 (21%) did not. Of the 317
hat used insecticide – treated bednets, 29 (9%) were positive for
alaria parasite while 75(90.4%)of the 83 that did not use insec-
icide bednets were positive for malaria parasite (P <0.05). Ebony
ospital had the highest compliance rate in the usage of LLINs at
6%while Aluuhealthcare centre had the lowest compliance rate at
2% (P <0.05). Those attending ANC in Private Health facilities had
0% compliancewhile 72.8% of those attending ANC in government
ealthcare centres used LLINs (P <0.05). Pregnant women in their
rst, second and third trimesters that used LLINs had prevalence
ates of 5.3%, 12.2%and11.5% respectivelywhile those in equivalent
rimesters that didnot use LLINshad83.6%, 94.1% and90.9% respec-
ively. Primigraviidae, secundigraviidae and multiparous women
hat used LLINs had prevalence rates of 10.3%, 8.7% and 5.9% respec-
ively while their counterparts who did not use LLINs had 95.8%,
9.5% and 75% respectively, (P <0.05). Increased levels of formal
ducation enhanced the compliance and usage of LLINs.
Conclusion: LLINSwas effective in the control of malaria and
fforts should be made to ensure high compliance rates as shown
n the study.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.710fectious Diseases 16S (2012) e158–e316 e169
Type: Poster Presentation
Final Abstract Number: 42.040
Session: Parasitology & Parasitic Infections
Date: Thursday, June 14, 2012
Time: 12:45-14:15
Room: Poster & Exhibition Area
Clinical investigation of in-vivo susceptibility ofP. falciparum to
artesunate in Binh Phuoc Province, Vietnam
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Hong2, L. Le Thanh4, N. Nguyen Thanh Thuy2, C. Nguyen Thuy
Nha5, T. Pham Van2
1 hospital for tropical diseases, Ho Chi Minh, Viet Nam
2 Oxford University Clinical Research Unit, Ho Chi Minh, Viet Nam
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Background: Since 2005 the ﬁrst-choice treatment for uncom-
plicated falciparum malaria recommended in Vietnam has been
the combinationof dihydroartemisinin (ametabolite of artesunate)
andpiperaquine. There areworrying signs of artemisinin resistance
inWesternCambodia. Vietnamshares a long landborderwithCam-
bodia and a large number of people cross that border on a regular
basis. In this context there is an urgent need to investigate whether
there is any evidence of resistance to artemisinin derivatives in
Vietnam.
Methods: This is a randomized clinical descriptive study in
uncomplicated falciparum malaria, comparing two different arms
of artesunate therapy (2 or 4mg/kg/day for 3 days) and an arm
of dihydroartemisinin-piperaquine for 3 days. Clinical and para-
sitological parameters were monitored over a 42-day follow-up
period.
Results: From August 2010 to May 2011, we recruited 166
patients into the study at the time of completion. Admission clin-
ical parameters and laboratory investigations were similar in 3
randomised groups. Fever clearance times did not differ signiﬁ-
cantly between the three study arms (artesunate 2mg/kg, 4mg/kg
and dihydroartemisinin-piperaquine) (30,24 and 24hrs; p =0.86).
Early treatment failure occurred in 3 (5%) and late clinical failure
occurred in 1 (2%) of the 55 patients in artesunate 2mg/kg arm,
as compared with none in other 2 study arms. Late parasitological
failure occurred in 1 (2%) of the 55 patients in dihydroartemisinin-
piperaquine arm. The rate of adequate clinical and parasitological
responses in 3 groups were 84%, 82% and 93%. Parasite clearance
time was not signiﬁcantly different between 3 regimens (p= 0.49).
The proportions of patients had parasitemia at 72hours were 27%,
27% and 22% after starting the treatment. The median parasite-
reduction ratios at 24hourswere 2.07% (interquartile range, 0.36 to
20.11), 0.49% (IR, 0.03 to 8.88) and 0.88% (IR, 0.18 to 8.49) (p =0.02).
Conclusion: This study indicates there is a suspected resistance
to artemisinin derivatives in the study site. The parasite-reduction
ratio at 24hours was signiﬁcantly slower in artesunate 2mg/kg
group. The results from the pharmacokinetic and genetic analysis
will clarify theartemisinin resistance. But, analternative antimalar-
ial regimen is not urgently needed.
http://dx.doi.org/10.1016/j.ijid.2012.05.711
